Severe nausea requiring treatment discontinuation was rare in monotherapy trials, with only about 1% of participants in the REDEFINE 1 trial stopping treatment because of adverse events overall
Enrollment in a formal behavioral modification program was a common requirement for access to semaglutide, which could create barriers to access, as there is ambiguity around what formal enrollment means and who will pay for these programs as well as a lack of data to support the use of these programs for weight loss
If you need to discuss patterns with your healthcare provider, PDF export can turn those notes into something easier to review
TAS, DK, TS worked together to make the figures
Step 2: Complete an Online Visit Conducted entirely online at your convenience, this visit allows your provider to review your personal health information, including medical history, weight loss aims, and any current medications
Ready-to-Use Glucagon is Preferred: For unconscious patients without IV access, use intranasal or prefilled syringe glucagon preparations
